Sienna Biopharmaceuticals raised $40M Series B venture round, led by ARCH Venture Partners.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
Venvest CapitalLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | David Pyott |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$86M
Top Valuation
-
Sienna Biopharmaceuticals raised $40M in a Series B round.
The round was announced on 04/24/17.
The round was led by ARCH Venture Partners, Venvest Capital.